Medical Cannabis Giants Get OK for New York Recreational Market

New entrants include Curaleaf and Columbia Care.

I Stock 1422217633

New York cannabis regulators have given the go-ahead to several of the state’s largest medical operators to participate in the adult-use recreational market. The organizations have registered as adult-use cultivators, processors and distributors

The Cannabis Control Board approved the following registered organizations to participate in the adult-use market:

  • Columbia Care NY, LLC
  • Curaleaf NY, LLC
  • Etain, LLC
  • PharmaCann of New York, LLC
  • Valley Agriceuticals, LLC

As Green Market Report pointed out, Etain is owned by Riv Capital, NYCANNA is owned by Acreage, and Valley Agriceuticals in owned by Cresco Labs.

The Office of Cannabis Management also announced that the Cannabis Growers’ Showcase (CGS) would be winding down before the end of the year as the state looks ahead to new stores opening over the next few weeks and months. To date, the CGS program has contributed to New York's cannabis industry by generating more than $4 million in sales. This is part of the state's overall performance in cannabis sales, which totals more than $110 million in 2023 through dispensaries and showcases.

"The CGS program facilitated collaboration between growers, conditional adult-use retailers, and processors, catalyzing the expansion of the state's cannabis market. This innovative model has brought substantial benefits to all stakeholders involved, ensuring the availability of legal cannabis access in areas without dispensaries and maintaining competitive prices for consumers," the OCM wrote.

More in Distribution